FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novartis Consumer Health Maalox Nighttime Antacid with Acid Reflux Recall

Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid)…

Novartis Consumer Health · Lincoln, NE

Risk level
Class III
Reported by FDA
Aug 28, 2013
Recall ID
D-910-2013
Check your lot numberHow we source this data

Summary

Novartis Consumer Health recalled Maalox Nighttime Antacid with Acid Reflux starting Aug 6, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-910-2013 on Aug 28, 2013. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Product description

Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Cherry flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10090 6.

Lot numbers, UPCs & expiration codes

Lot #: 10114318, Exp 01/14

Where it was sold

Nationwide, Canada, and Panama.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-910-2013
Classification
Class III
Status
Terminated
Recall initiated
Aug 6, 2013
FDA report date
Aug 28, 2013
Quantity
11,760 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Novartis Consumer Health

Original FDA data

Every field from FDA enforcement report D-910-2013, exactly as published.

Show all FDA fields
City
Lincoln
State
NE
Status
Terminated
Country
United States
Event ID
65840
Address
10401 Hwy 6
Code information
Lot #: 10114318, Exp 01/14
Postal code
68517-9626
Report date
Aug 28, 2013
Product type
Drugs
Recall number
D-910-2013
Classification
Class III
Recalling firm
Novartis Consumer Health
Product quantity
11,760 bottles
Termination date
Nov 4, 2014
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Maalox Nighttime Antacid with Acid Reflux Barrier (calcium carbonate and alginic acid) chewable tablets, 500 mg/200 mg, Cherry flavor, 65-count tablets per bottle, Novartis Consumer Health Canada Inc., Mississauga, ON L5N 2X7, foreign labeling containing English and French, NPN 80000899, UPC 0 58478 10090 6.
Distribution pattern
Nationwide, Canada, and Panama.
Recall initiation date
Aug 6, 2013
Initial firm notification
Letter
Center classification date
Aug 20, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-910-2013, published Aug 28, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls